First-in-human phase 1/1b expansion of PMD-026, an oral RSK inhibitor, in patients with metastatic triple-negative breast cancer.Muralidhar Beeram,Pavani Chalasani,Judy S. Wang,Lida A. Mina, Rebecca Arielle Shatsky,Meghna S. Trivedi,Robert Wesolowski,Sara A. Hurvitz,Hyo S. Han,Amita Patnaik,Mary Rose Pambid,Aarthi Jayanthan, My-My Huynh, Gerrit Los,Sandra Elaine Dunn, Andrew DorrJOURNAL OF CLINICAL ONCOLOGY(2021)引用 3|浏览6暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要